Plant Health Care: Peptides by PHC are differentiated and protect plants from inside out with no harm to food, humans, and the environment

Despite all challenges that impacted Agribusiness in 2023, Plant Health Care reaches the end of the year having made significant achievements.

Harpin Protein business globally continued to provide consistent results for growers and we continue to add new partnerships. As part of Plant Health Care’s corporate strategy, Harpin αβ plays an important role, as it enables plants to fully develop their productive potential and delivering higher yields.

Following the initial regulatory approval in France in October 2022, Plant Health Care has pursued Mutual Recognition to expand the use of Harpin αβ across Europe and Poland is the first EU country to grant this status for Harpin αβ. Europe is the world's largest market for sustainable agriculture with annual sales of over $2 billion.

Following the successful launch of SAORI^® in Brazil, technologies from Plant Health Care’s PREtec platforms continued to be launched across different regions and new registrations were granted: Obrona™ (USA), Moshy™ (Brazil), among others. These technologies protect crops against important diseases and improve yield.

Regarding the nematicide technology, TEIKKO™, Plant Health Care is already on the field preparing the commercial launch in Brazil for 2024/2025 soybean crop season. United States and Mexico registrations were already submitted.

The next generation of crop protection biological technologies that Companies are planning to launch in the future, PHC is already commercializing globally.

"Our Peptides are differentiated and protect plants from inside out, with no harm to food, humans, and the environment. Peptides by PHC." Jeff Tweedy, CEO of Plant Health Care concluded.